

Who competes with Merck KGaA (MRK.XETRA)? Public peers with tickers and private competitors with AI-sourced descriptions.
View full stock analysis →Merck KGaA (MRK.XETRA) operates across three distinct divisions: Healthcare, delivering prescription medicines and dermatology treatments; Life Science, providing laboratory reagents, tools and services; and Electronics, supplying materials and specialty chemicals. The competitive landscape spans large global pharmaceutical and life-science players alongside specialty chemical and diagnostics manufacturers. Material risks include patent expiration and biosimilar competition, regulatory and pricing pressures, execution on pipeline and R&D initiatives, and exposure to macroeconomic fluctuations, foreign exchange movements, and integration challenges from prior acquisitions.
| Company | Ticker |
|---|---|
| Bayer AG | BAYN.XETRA |
| Novartis AG | NOVN.SIX |
| Thermo Fisher Scientific Inc. | TMO.NYSE |
| Danaher Corporation | DHR.NYSE |
Privately controlled global pharmaceutical company that competes with Merck KGaA across prescription medicines, animal health, and research collaborations in overlapping therapeutic areas.
Family-owned healthcare group with operations in aesthetics, dermatology, and specialty therapeutic products, competing in markets where Merck KGaA maintains a presence in dermatology and life-science adjacent sectors.
Receive hand-picked stock recommendations with detailed analyses every week
Start Free Trial